Skip to main content

MIRI PI Dr. Yen Receives TISUA Award

April 8, 2022

MIRI PI Dr. Yen receives TISUA Award.

Elizabeth Yen, MD, MA

MIRI is that proud to announce that PI Dr. Elizabeth Yen received seed funding from the Tufts Initiative on Substance Use and Addiction Program for the grant Sex-Specific Neural Mechanisms Underlying Prenatal Opioid-Induced Feeding Dysregulation and Metabolic Risks.”

The goal of this initiative, announced by the Office of the Vice Provost for Research in collaboration with Tufts Medical Center, is to establish sustainable efforts using Tufts’ unique constellation of clinical expertise, research, scholarship and commitment to civic engagement, to help the countless individuals and families who have suffered as a result of the opioid crisis.

Dr. Elizabeth Byrnes of Cummings School of Veterinary Medicine is team lead. This grant will focus on understanding the sex-specific impact of prenatal opioids on the developing brain and metabolic risks. With a translational research focus by Dr. Yen that is clinically driven, Dr. Byrnes’s animal research complements Dr. Yen’s research and enables mechanistic approaches to study the intersection between opioid, brain reward signaling and neuroinflammation that may explain aberrant feeding and growth trajectory in opioid-exposed offspring and the risk of adverse metabolic outcomes.

Learn more about Dr. Yen’s research here.

Jonathan Davis, MD
Articles
Tufts Medicine physician helps lead national effort to accelerate pediatric medical device innovation
December 4, 2025
A Tufts Medicine neonatologist is helping chart a new national path to improve how medical devices are developed for children—a long-standing gap in U.S. healthcare.
Articles
Tufts Medicine-led Research: Rapid Genome Sequencing Can Save $160K per Patient
November 17, 2025
Early rapid genome sequencing can save $160K per patient, new Tufts Medicine-led study shows
Two people standing with a bookshelf behind them.
Articles
Tufts Medical Center-Led Study Identifies Safer Path Forward for Cancer Patients at Risk of Heart Disease
August 6, 2025
Tufts Medical Center researchers find safer cancer drug option for patients at risk of heart disease, identifying a key mechanism behind treatment-related cardiac events.

Be among the first to know

Enjoy the latest health updates from Tufts Medicine by signing up for our e-newsletter today.

Jump back to top